John Demaree's Net Worth
-$86.3 Thousand
Who is John Demaree?
John Demaree does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Karyopharm Therapeutics Inc., and G1 Therapeutics, Inc..
SEC CIK
John Demaree's CIK is 0001744959
Past Insider Trading and Trends
2020 was John Demaree's most active year for acquiring shares with 3 total transactions. John Demaree's most active month to acquire stocks was the month of January. 2020 saw John Demaree paying a total of $109,012.50 for 188,700 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +194.56% | 15.85K |
—
|
—
| 24K |
Feb 25
| |||
Form 4
|
∞
| 7.5K |
$14.54 | $109,012.50 | 7.5K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +23.53% | 1K |
$33.15 | $33,151.10 | 5.25K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||